← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2012Last known activity
Apr 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT05911906CollaboratorPhase 4Apr 1, 2024
- NCT06163989Lead sponsorN/AFeb 1, 2024
- NCT06163989Reponsible party - principal investigatorN/AFeb 1, 2024
- NCT06163989Study directorN/AFeb 1, 2024
- NCT05329610CollaboratorN/AApr 5, 2022
- NCT03621046Lead sponsorPhase 2Aug 20, 2018
- NCT03621046Study directorPhase 2Aug 20, 2018
- NCT02417116Overall official - principal investigatorN/AJun 1, 2015
- NCT02417116Lead sponsorN/AJun 1, 2015
- NCT01569191Lead sponsorPhase 4Mar 1, 2012
Details
- Last known activity
- Apr 1, 2024